跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺和灵50R - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mixed Protamine Human Insulin Injection (50R)
Approved
生物制品
Mixed Protamine Human Insulin Injection (50R)
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Dec 8, 2021
Approval ID
8G5JDQbfo4e
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
8G5JDQbfo4e
Approval Number
国药准字SJ20201009
Generic Name
50/50混合重组人胰岛素注射液
Generic Name En
Mixed Protamine Human Insulin Injection (50R)
Trade Name
诺和灵50R
Drug Type
生物制品
Dosage Form
注射剂
Strength
300IU/3ml/支(笔芯)
Reg Date
2021-12-08
Expired Date
2026-12-07
Company Name
Novo Nordisk A/S
Production Company Name
Novo Nordisk A/S
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 8, 2021
Approval ID
8G5JDQbfo4e
Type
生物制品
Back to NMPA Approvals
